{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T06:06:54Z","timestamp":1783490814083,"version":"3.55.0"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2014,8,29]],"date-time":"2014-08-29T00:00:00Z","timestamp":1409270400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0106422","type":"journal-article","created":{"date-parts":[[2014,8,29]],"date-time":"2014-08-29T18:20:32Z","timestamp":1409336432000},"page":"e106422","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":33,"title":["Prolonged Prophylactic Protection from Botulism with a Single Adenovirus Treatment Promoting Serum Expression of a VHH-Based Antitoxin Protein"],"prefix":"10.1371","volume":"9","author":[{"given":"Jean","family":"Mukherjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Dmitriev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Debatis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline M.","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Beamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena A.","family":"Kashentseva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Curiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles B.","family":"Shoemaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,8,29]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1517\/17460441.2014.884066","article-title":"Current strategies for designing antidotes against botulinum neurotoxins","volume":"9","author":"K Patel","year":"2014","journal-title":"Expert Opin Drug Discov"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrmicro977","article-title":"Antitoxins: novel strategies to target agents of bioterrorism","volume":"2","author":"GJ Rainey","year":"2004","journal-title":"Nature reviews Microbiology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3201\/eid0808.010516","article-title":"Passive antibody administration (immediate immunity) as a specific defense against biological weapons","volume":"8","author":"A Casadevall","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ab.2012.08.005","article-title":"Engineered domain-based assays to identify individual antibodies in oligoclonal combinations targeting the same protein","volume":"430","author":"Q Meng","year":"2012","journal-title":"Anal Biochem"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e29941","DOI":"10.1371\/journal.pone.0029941","article-title":"A novel strategy for development of recombinant antitoxin therapeutics tested in a mouse botulism model","volume":"7","author":"J Mukherjee","year":"2012","journal-title":"PLoS ONE"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Tremblay JM, Mukherjee J, Leysath CE, Debatis M, Ofori K, <etal>et al<\/etal>.. (2013) A single VHH-based toxin neutralizing agent and an effector antibody protects mice against challenge with Shiga toxins 1 and 2. Infect Immun.","DOI":"10.1128\/IAI.01033-13"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Vance DJ, Tremblay JM, Mantis NJ, Shoemaker CB (2013) Stepwise Engineering of Heterodimeric Single Domain Camelid VHH Antibodies that Passively Protect Mice from Ricin Toxin. J Biol Chem.","DOI":"10.1074\/jbc.M113.519207"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1128\/IAI.01084-09","article-title":"Efficient serum clearance of botulinum neurotoxin achieved using a pool of small antitoxin binding agents","volume":"78","author":"J Sepulveda","year":"2010","journal-title":"Infect Immun"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1128\/IAI.00856-08","article-title":"Adenovirus-mediated delivery of an anti-V antigen monoclonal antibody protects mice against a lethal Yersinia pestis challenge","volume":"77","author":"C Sofer-Podesta","year":"2009","journal-title":"Infect Immun"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/sj.mt.6300344","article-title":"Rapid\/sustained anti-anthrax passive immunity mediated by co-administration of Ad\/AAV","volume":"16","author":"BP De","year":"2008","journal-title":"Mol Ther"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ymthe.2004.10.018","article-title":"Passive immunotherapy for anthrax toxin mediated by an adenovirus expressing an anti-protective antigen single-chain antibody","volume":"11","author":"K Kasuya","year":"2005","journal-title":"Mol Ther"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1089\/10430340260185111","article-title":"High in vivo production of a model monoclonal antibody on adenoviral gene transfer","volume":"13","author":"D Noel","year":"2002","journal-title":"Hum Gene Ther"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.virol.2008.04.016","article-title":"Genetic delivery of an anti-RSV antibody to protect against pulmonary infection with RSV","volume":"378","author":"D Skaricic","year":"2008","journal-title":"Virology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nbt1087","article-title":"Stable antibody expression at therapeutic levels using the 2A peptide","volume":"23","author":"J Fang","year":"2005","journal-title":"Nat Biotechnol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/sj.mt.6300142","article-title":"An antibody delivery system for regulated expression of therapeutic levels of monoclonal antibodies in vivo","volume":"15","author":"J Fang","year":"2007","journal-title":"Mol Ther"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"8769","DOI":"10.1128\/JVI.76.17.8769-8775.2002","article-title":"Generation of neutralizing activity against human immunodeficiency virus type 1 in serum by antibody gene transfer","volume":"76","author":"AD Lewis","year":"2002","journal-title":"J Virol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1099\/vir.0.83670-0","article-title":"Delivery of single-chain antibodies (scFvs) directed against the 37\/67 kDa laminin receptor into mice via recombinant adeno-associated viral vectors for prion disease gene therapy","volume":"89","author":"C Zuber","year":"2008","journal-title":"J Gen Virol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.antiviral.2012.12.021","article-title":"Passive immunization with a recombinant adenovirus expressing an HA (H5)-specific single-domain antibody protects mice from lethal influenza infection","volume":"97","author":"IL Tutykhina","year":"2013","journal-title":"Antiviral Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0958-1669(02)00352-X","article-title":"Pharmacokinetics and biodistribution of genetically engineered antibodies","volume":"13","author":"SK Batra","year":"2002","journal-title":"Curr Opin Biotechnol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/protein\/gzl011","article-title":"The pharmacokinetics of an albumin-binding Fab (AB.Fab) can be modulated as a function of affinity for albumin","volume":"19","author":"A Nguyen","year":"2006","journal-title":"Protein engineering, design & selection : PEDS"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1006\/viro.1997.8695","article-title":"Baculovirus expression of a human G2-specific, neutralizing IgG monoclonal antibody to Puumala virus","volume":"235","author":"M Liang","year":"1997","journal-title":"Virology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0022-1759(01)00353-2","article-title":"High level expression of a human rabies virus-neutralizing monoclonal antibody by a rhabdovirus-based vector","volume":"252","author":"K Morimoto","year":"2001","journal-title":"J Immunol Methods"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"6179","DOI":"10.1158\/1078-0432.CCR-06-0746","article-title":"Gene therapy using adenovirus-mediated full-length anti-HER-2 antibody for HER-2 overexpression cancers","volume":"12","author":"M Jiang","year":"2006","journal-title":"Clin Cancer Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1517\/17425247.2014.874414","article-title":"Utilizing adenovirus vectors for gene delivery in cancer","volume":"11","author":"D Kasala","year":"2014","journal-title":"Expert Opin Drug Deliv"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/B978-0-12-398342-8.00002-1","article-title":"Chapter two\u2013Adenovirus strategies for tissue-specific targeting","volume":"115","author":"MS Beatty","year":"2012","journal-title":"Adv Cancer Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.bbapap.2006.05.011","article-title":"Reliable and controllable antibody fragment selections from Camelid non-immune libraries for target validation","volume":"1764","author":"P Verheesen","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/protein\/gzp002","article-title":"Immunological applications of single-domain llama recombinant antibodies isolated from a naive library","volume":"22","author":"A Monegal","year":"2009","journal-title":"Protein Eng Des Sel"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/978-1-61779-968-6_26","article-title":"Affinity maturation of single-domain antibodies by yeast surface display","volume":"911","author":"A Koide","year":"2012","journal-title":"Methods Mol Biol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1146\/annurev-biochem-063011-092449","article-title":"Nanobodies: natural single-domain antibodies","volume":"82","author":"S Muyldermans","year":"2013","journal-title":"Annu Rev Biochem"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.2217\/nnm.13.86","article-title":"Nanobodies and their potential applications","volume":"8","author":"G Hassanzadeh-Ghassabeh","year":"2013","journal-title":"Nanomedicine (Lond)"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fonc.2012.00159","article-title":"Idiotypes as immunogens: facing the challenge of inducing strong therapeutic immune responses against the variable region of immunoglobulins","volume":"2","author":"A Lopez-Requena","year":"2012","journal-title":"Front Oncol"},{"key":"ref32","first-page":"3101s","article-title":"Generation and monitoring of cell lines producing humanized antibodies","volume":"5","author":"MJ Losman","year":"1999","journal-title":"Clin Cancer Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"5152","DOI":"10.1182\/blood-2009-04-214569","article-title":"In vivo delivery of a microRNA-regulated transgene induces antigen-specific regulatory T cells and promotes immunologic tolerance","volume":"114","author":"A Annoni","year":"2009","journal-title":"Blood"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1002\/hep.24230","article-title":"Hepatocyte-targeted expression by integrase-defective lentiviral vectors induces antigen-specific tolerance in mice with low genotoxic risk","volume":"53","author":"J Matrai","year":"2011","journal-title":"Hepatology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1021\/mp100310h","article-title":"Pharmacological interventions for improving adenovirus usage in gene therapy","volume":"8","author":"HJ Haisma","year":"2011","journal-title":"Mol Pharm"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"8798","DOI":"10.1128\/JVI.71.11.8798-8807.1997","article-title":"The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors","volume":"71","author":"A Lieber","year":"1997","journal-title":"J Virol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"5368","DOI":"10.1128\/JVI.78.10.5368-5381.2004","article-title":"Analysis of adenovirus sequestration in the liver, transduction of hepatic cells, and innate toxicity after injection of fiber-modified vectors","volume":"78","author":"DM Shayakhmetov","year":"2004","journal-title":"J Virol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jviromet.2007.08.009","article-title":"A quantitative assay for measuring clearance of adenovirus vectors by Kupffer cells","volume":"147","author":"JS Smith","year":"2008","journal-title":"J Virol Methods"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1006\/mthe.2000.0227","article-title":"Sequestration of adenoviral vector by Kupffer cells leads to a nonlinear dose response of transduction in liver","volume":"3","author":"N Tao","year":"2001","journal-title":"Mol Ther"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1128\/JVI.71.1.624-629.1997","article-title":"Enhancement of in vivo adenovirus-mediated gene transfer and expression by prior depletion of tissue macrophages in the target organ","volume":"71","author":"G Wolff","year":"1997","journal-title":"J Virol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1089\/hum.1997.8.1-37","article-title":"Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration","volume":"8","author":"S Worgall","year":"1997","journal-title":"Hum Gene Ther"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1038\/sj.gt.3301301","article-title":"Production of first generation adenovirus vectors: a review","volume":"7","author":"X Danthinne","year":"2000","journal-title":"Gene Ther"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1399-0004.2000.580101.x","article-title":"Improvements in adenoviral vector technology: overcoming barriers for gene therapy","volume":"58","author":"RJ Parks","year":"2000","journal-title":"Clin Genet"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S1359-6446(99)01433-6","article-title":"Adenovirus technology for gene manipulation and functional studies","volume":"5","author":"II Wang","year":"2000","journal-title":"Drug Discov Today"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.copbio.2011.06.012","article-title":"Strategies for extended serum half-life of protein therapeutics","volume":"22","author":"RE Kontermann","year":"2011","journal-title":"Curr Opin Biotechnol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/nprot.2007.135","article-title":"A protocol for rapid generation of recombinant adenoviruses using the AdEasy system","volume":"2","author":"J Luo","year":"2007","journal-title":"Nat Protoc"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1073\/pnas.95.5.2509","article-title":"A simplified system for generating recombinant adenoviruses","volume":"95","author":"TC He","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1099\/0022-1317-36-1-59","article-title":"Characteristics of a human cell line transformed by DNA from human adenovirus type 5","volume":"36","author":"FL Graham","year":"1977","journal-title":"J Gen Virol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1089\/hum.1996.7.2-215","article-title":"Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors","volume":"7","author":"FJ Fallaux","year":"1996","journal-title":"Hum Gene Ther"},{"key":"ref50","first-page":"115","article-title":"The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12","volume":"36","author":"JV Maizel Jr","year":"1968","journal-title":"Virology"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0106422","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T09:04:48Z","timestamp":1689498288000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0106422"}},"subtitle":[],"editor":[{"given":"Daniel","family":"Gillet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,8,29]]},"references-count":50,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2014,8,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0106422","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,29]]}}}